跳至主要内容
临床试验/TCTR20240515008
TCTR20240515008尚未招募4 期

A Comparison of Daily and Alternate-Day Prednisolone Therapy in the Treatment of Myasthenia Gravis: A pilot study

Siriraj Hospital0 个研究点目标入组 60 人开始时间: 2024年5月15日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Age 18-80 years old
  • Patients with diagnosis of myasthenia gravis at Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Patients who have indication for corticosteroid Generalized MG or Ocular MG that not in minimal manifestation state (MMS) after taken Pyridostigmine more than 360 mg/d

排除标准

  • Patients who presented with myasthenic crisis
  • Patients who have contraindication to corticosteroids : uncontrolled infection, uncontrolled diabetes mellitus (HbA1C 9.0), severe osteoporosis (the threshold of bone density value < -2.5 SD of T-score)
  • Patients who are currently receiving corticosteroids treatment
  • Body weight more than 100 Kg
  • Patients who are Anti-MuSK Ab positive
  • Patients who are corticosteroids, Azathioprine or Mycophenolate mofetil allergy
  • Patients who are currently pregnancy or lactation
  • Patients who are terminally ill
  • Patients who have active infection including TB, HBV, HCV and HIV

研究者

相似试验